Martina Wolff

Martina Wolff

Auto-generated profile, based on publicly available information

Martina Wolff

Institut für Transfusionsmedizin, Universitätsmedizin Greifswald, Greifswald, Germany

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2021 in Blood
Verified
Journal Article
Open access
PDF file
SHStefan Handtke
Stefan Handtke
MWMartina Wolff
Martina Wolff
CZCarlo Zaninetti
Carlo Zaninetti
JWJan Wesche
Jan Wesche
LSLinda Schönborn
Linda Schönborn
AGAndreas Greinacher
Andreas Greinacher
Vaccination is crucial in combatting the severe acute respiratory syndrome coronavirus 2 pandemic. The rare complication of thrombocytopenia and thrombotic complications at unusual sites after ChAdOx1 nCov-19 vaccination is caused by platelet-activating antibodies directed against platelet factor 4 (PF4). We present a widely applicable whole-blood standard flow cytometric assay to identify the pathogenic antibodies associated with vaccine-induced immune-mediated thrombotic thrombocytopenia (VITT) after ChAdOx1 nCov-19 vaccination. This assay will enable rapid diagnosis by many laboratories. This trial was registered at www.clinicaltrials.gov as #NCT04370119.

25 August 2022 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Open access
LSLinda Schönborn
Linda Schönborn
TTThomas Thiele
Thomas Thiele
MEMax Esefeld
Max Esefeld
KDKhalil El Debuch
Khalil El Debuch
JWJan Wesche
Jan Wesche
AGAndreas Greinacher
Andreas Greinacher
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a prothrombotic, heparin-induced thrombocytopenia (HIT)-mimicking, adverse reaction caused by platelet-activating anti-platelet factor 4 (PF4) antibodies that occurs rarely after adenovirus vector-based COVID-19 vaccination. Strength of PF4-dependent enzyme immunoassay (EIA) reactivity-judged by optical density (OD) measurements-strongly predicts platelet-activating properties of HIT antibodies in a functional test. Whether a similar relationship holds for VITT antibodies is unknown. To evaluate probability for positive platelet activation testing for VITT antibodies based upon EIA OD reactivity; and to investigate simple approaches to minimize false-negative platelet activation testing for VITT. All samples referred for VITT testing were systematically evaluated by semiquantitative in-house PF4/heparin-EIA (OD readings) and PF4-induced platelet activation (PIPA) testing within a cohort study. EIA-positive sera testing PIPA-negative were retested following 1/4 to 1/10 dilution. Logistic regression was performed to predict the probability of a positive PIPA per magnitude of EIA reactivity. Greater EIA ODs in sera from patients with suspected VITT correlated strongly with greater likelihood of PIPA reactivity. Of 61 sera (with OD values >1.0) testing negative in the PIPA, a high proportion (27/61, 44.3%) became PIPA positive when tested at 1/4 to 1/10 dilution. VITT serology resembles HIT in that greater EIA OD reactivity predicts higher probability of positive testing for platelet-activating antibodies. Unlike the situation with HIT antibodies, however, diluting putative VITT serum increases probability of a positive platelet activation assay, suggesting that optimal complex formation depends on the stoichiometric ratio of PF4 and anti-PF4 VITT antibodies.

1 January 2012
Verified
Book Chapter
Closed access
PDF file
MWMartina Wolff
Martina Wolff
"SELF, IDENTITY AND TERRORISM IN CURRENT AMERICAN LITERATURE: AMERICAN PASTORAL AND TERRORIST" published on 01 Jan 2012 by Brill | Rodopi.

20 September 2026 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Open access
MWMartina Wolff
Martina Wolff
COCelina Owczarek
Celina Owczarek
AGAndreas Greinacher
Andreas Greinacher